Projecten per jaar
Vingerafdruk
- 1 Soortgelijke profielen
Netwerk
-
iBOF/23/043: MATRACs: Membraan-bindende chimere therapeutica
Laoui, D., Devoogdt, N., De Geest, B. & Lambrecht, B.
1/01/23 → 31/12/26
Project: Fundamenteel
-
FWOTM1119: Onderzoek en inhibitie van Epstein-Barr Virus immuun ontwijking via BILF1-modulerende nanobodies
1/11/22 → 31/10/25
Project: Fundamenteel
Onderzoeksoutput
-
A comparison of [68Ga]Ga-NOTA-anti-HER2-sdAb PET/CT with [18F]FDG-PET/CT in breast carcinoma patients.
Gondry, O., Xavier, C., Heemskerk, J., Raes, L. A. J., Debacker, J., De Geeter, F., Fontaine, C., Vanhoeij, M., Aspeslagh, S., Joris, S., De Grève, J., Verfaillie, G., Luyten, I., De Mey, L., Vandenbroucke, F., Waelput, W., Glorieus, K., Bourgeois, S., Cousaert, J., Vaneycken, I. & 5 anderen, , 2023.Onderzoeksoutput: Unpublished abstract
-
Characterization of CD163-specific nanobody-based immunotracers for non-invasive imaging of immunosuppressive macrophages.
Lauwers, Y., De Groof, T., Emami, M., Vincke, C., Van Craenenbroeck, J., Raes, G., Van Ginderachter, J. & Devoogdt, N., 2023.Onderzoeksoutput: Poster
-
Development of a new immunotracer targeting human CD8+ cytotoxic T cells through recognition of the CD8β chain
De Groof, T., Lauwers, Y., De Pauw, T., Vincke, C., Van Craenenbroeck, J., Raes, G., Van Ginderachter, J. & Devoogdt, N., 2023.Onderzoeksoutput: Unpublished abstract
-
In vivo optical imaging using a novel fluorescently-labeled single-domain antibody targeting a universal tumor marker
Mateusiak, L., Floru, S., Wouters, J., De Groof, T., Declerck, N., Janssen, S., Debie, P., Zeven, K., Puttemans, J., Breckpot, K., Devoogdt, N. & Hernot, S., 28 jan 2023.Onderzoeksoutput: Unpublished abstract
-
Molecular imaging of liver inflammation using an anti-VCAM-1 nanobody
Nachit, M., Montemagno, C., Clerc, R., Ahmadi, M., Briand, F., Bacot, S., Devoogdt, N., Serdjebi, C., Ghezzi, C., Sulpice, T., Broisat, A., Leclercq, I. A. & Perret, P., 24 feb 2023, In: Nature Communications. 14, 1, 1062.Onderzoeksoutput: Article › peer review
Open Access
Prijzen
-
Alavi-Mandell Award from Journal of Nuclear Medicine
Krasniqi, Ahmet (Recipient), D'Huyvetter, Matthias (Recipient), Devoogdt, Nick (Recipient) & Keyaerts, Marleen (Recipient), 16 apr 2019
Prijs: Prize (including medals and awards)
-
Certificat of Young Speaker Award
Lecocq, Quentin (Recipient), Broos, K. (Recipient), Bridoux, Jessica (Recipient), Raes, Geert (Recipient), Xavier, Catarina (Recipient), Devoogdt, Nick (Recipient), Keyaerts, Marleen (Recipient) & Breckpot, Karine (Recipient), 1 feb 2019
Prijs: Prize (including medals and awards)
Bestand -
Development of a nanoCAR-T cell approach for the treatment of multiple myeloma
Hanssens, Heleen (Recipient), Devoogdt, Nick (Recipient), De Veirman, Kim (Recipient) & Breckpot, Karine (Recipient), 15 dec 2021
Prijs: Fellowship awarded competitively
-
Development of a radiotracer and small protein inhibitor against the novel immune checkpoint TIGIT
Zeven, Katty (Recipient), Devoogdt, Nick (Recipient) & Breckpot, Karine (Recipient), 15 dec 2020
Prijs: Fellowship awarded competitively
-
ESMI presentation award for best oral presentation
Bridoux, Jessica (Recipient), Broos, K. (Recipient), Lecocq, Quentin (Recipient), Crauwels, M. (Recipient), Martin, Charlotte (Recipient), Cleeren, F. (Recipient), Kondrashov, M. (Recipient), Ballet, Steven (Recipient), Bormans, G. (Recipient), Schou, M. (Recipient), Elmore, C. (Recipient), Raes, Geert (Recipient), Breckpot, Karine (Recipient), Muyldermans, Serge (Recipient), Devoogdt, Nick (Recipient), Keyaerts, Marleen (Recipient), Caveliers, Vicky (Recipient) & Xavier, Catarina (Recipient), 17 jan 2020
Prijs: Prize (including medals and awards)
Activiteiten
-
Characterization of CD163-specific nanobody-based immunotracers for non-invasive imaging of immunosuppressive macrophages
Yoline Lauwers (Speaker), Timo De Groof (Contributor), Nick Devoogdt (Contributor), Jo Van Ginderachter (Contributor), Maral Emami (Contributor), Cecile Vincke (Contributor) & Geert Raes (Contributor)
14 mrt 2023 → 17 mrt 2023Activiteit: Talk or presentation at a conference
-
AXL targeting using Bemcentinib increases chemosensitivity in Acute Myeloid Leukemia
Niels Vandewalle (Speaker), Laura Meysman (Contributor), Nathan De Beule (Contributor), Ann De Becker (Contributor), Hatice Satilmis (Contributor), Emma Verheye (Contributor), Rong Fan (Contributor), Elke De Bruyne (Contributor), Eline Menu (Contributor), Karin Vanderkerken (Contributor), Karine Breckpot (Contributor), Nick Devoogdt (Contributor) & Kim De Veirman (Contributor)
3 feb 2023Activiteit: Talk or presentation at a conference
-
In vivo optical imaging using a novel fluorescently-labeled single-domain antibody targeting a universal tumor marker
Lukasz Mateusiak (Speaker), Sam Floru (Contributor), Janne Wouters (Contributor), Timo De Groof (Contributor), Noemi Declerck (Contributor), Simone Janssen (Contributor), Pieterjan Debie (Contributor), Katty Zeven (Contributor), Janik Puttemans (Contributor), Karine Breckpot (Contributor), Nick Devoogdt (Contributor) & Sophie Hernot (Contributor)
28 jan 2023Activiteit: Talk or presentation at a conference
-
Using the site-specific radiolabeling of a PD-L1 nanobody via maleimide–cysteine chemistry to develop a PET-tracer as screening tool for personalized oncology treatment
Dora Mugoli Chigoho (Speaker), Jessica Bridoux (Speaker), Catarina Xavier (Speaker), Vicky Caveliers (Speaker), Marleen Keyaerts (Speaker), Nick Devoogdt (Speaker), Karine Breckpot (Speaker), Robin Maximilian Awad (Speaker) & Quentin Lecocq (Speaker)
7 mei 2022Activiteit: Talk or presentation at a conference
-
Development of an in vitro hot tumor model for immunotherapeutic drug screening
Robin Maximilian Awad (Presenter), Fien Meeus (Contributor), Yannick De Vlaeminck (Contributor), Nick Devoogdt (Contributor) & Karine Breckpot (Contributor)
21 sep 2022Activiteit: Talk or presentation at a conference
Knipsels
-
Betaalbare kankerimmunotherapie
Karine Breckpot, Nick Devoogdt, Yannick De Vlaeminck & Fien Meeus
8/02/22
1 item van Media-aandacht
Pers / media: !!Research
-
VUB-onderzoekers en start-up Esobiotec streven naar betaalbare kankerimmunotherapie
Karine Breckpot, Nick Devoogdt, Yannick De Vlaeminck & Fien Meeus
31/01/22
1 Mediabijdrage
Pers / media: !!Research
-
VUB-onderzoekers en start-up Esobiotec willen kankerimmunotherapie betaalbaarder maken
Karine Breckpot, Nick Devoogdt, Fien Meeus & Yannick De Vlaeminck
31/01/22
1 item van Media-aandacht
Pers / media: !!Research
-
EsoBiotec ready to transform cell therapy cancer treatments
Karine Breckpot & Nick Devoogdt
30/09/21
1 item van Media-aandacht
Pers / media: !!Research
-
Mini-antibodies discovered in sharks and camels could lead to drugs for cancer and other diseases
10/05/18
1 Mediabijdrage
Pers / media: !!Research
Scriptie
-
A novel generation of affitins for targeting cancer cells with drug-loaded lipid nanocapsules
Auteur: Kalichuk, V., Pecorari, F., Préat, V. & Devoogdt, N., 16 okt 2017Scriptie/Masterproef: Doctoral Thesis
-
Assessment of antigen-binding domain parameters important for adequate CAR-T-cell activation: evaluating different SLAMF7-targeting nanobodies.
Auteur: Meeus, F., Hanssens, H., De Veirman, K. & Devoogdt, N., 19 jun 2020Begeleider: Hanssens, H. (Advisor)
Scriptie/Masterproef: Master's Thesis
-
Bead based immunoassay of HER2 ECD domain using nanobodies
Auteur: Adaga, E., Muyldermans, S., De Pauw, P. & Devoogdt, N., 1 sep 2015Scriptie/Masterproef: Master's Thesis
-
CD20 Nb TRNT: targeted radionuclide therapy of non-hodgkin-lymphoma with anti-CD20 nanobodies
Auteur: Devoogdt, N., D'Huyvetter, M. & Tavernier, J., 24 mei 2019Scriptie/Masterproef: Doctoral Thesis
-
Characterization of CD69-targeting nanobodies as immunotracers
Auteur: Ndini, T., Van Ginderachter, J., Devoogdt, N., Vincke, C. & De Groof, T., sep 2021Scriptie/Masterproef: Master's Thesis